LUNG
Pulmonx Corporation$1.96-0.01 (-0.76%)Prev Close$1.97·MCap$95.5M·P/E—·Vol148.4K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
8
$263.3K
◆
Net Activity
Net Seller
$263.3K
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Pulmonx Corporation (LUNG) has been exclusively selling, with 0 insider purchases totaling $0.00 and 8 insider sales totaling $263.3K. The most recent insider transaction was by Radhakrishnan Srikanth (officer: Chief Science & Techn. Officer), who sold $32.2K worth of shares on Sep 3, 2026. Pulmonx Corporation operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $95.5M.
LUNG Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Radhakrishnan Srikanth | officer: Chief Science & Techn. Officer | Sell | 14,245 | $2.26 | $32.2K | 328,596 |
| Sep 3, 2026 | Rose Geoffrey Beran | officer: Chief Commercial Officer | Sell | 7,879 | $2.26 | $17.8K | 455,498 |
| Sep 3, 2026 | French Glendon E. III | director, officer: President and CEO | Sell | 41,882 | $2.26 | $94.7K | 1,175,720 |
| Sep 3, 2026 | Lehman David Aaron | officer: General Counsel | Sell | 14,334 | $2.26 | $32.4K | 372,354 |
| Dec 8, 2025 | Florin Daniel P | Director | Sell | 23,321 | $1.99 | $46.4K | 0 |
| Dec 1, 2025 | French Glendon E. III | President and CEO | Sell | 8,805 | $1.57 | $13.8K | 0 |
| Dec 1, 2025 | Lehman David Aaron | GENERAL COUNSEL | Sell | 10,278 | $1.57 | $16.1K | 0 |
| Dec 1, 2025 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,322 | $1.57 | $9.9K | 0 |
| Sep 2, 2025 | Joshi Mehul | Chief Financial Officer & PAO | Sell | 7,936 | $1.60 | $12.7K | 0 |
| Sep 2, 2025 | Lehman David Aaron | GENERAL COUNSEL | Sell | 9,769 | $1.60 | $15.6K | 0 |
| Sep 2, 2025 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,543 | $1.60 | $10.5K | 0 |
| Sep 2, 2025 | Williamson Steven S. | PRESIDENT AND CEO | Sell | 9,648 | $1.60 | $15.4K | 0 |
| Jun 12, 2025 | Ferrari Richard | Director | Sell | 8,000 | $3.16 | $25.3K | 0 |
| Jun 5, 2025 | Florin Daniel P | Director | Buy | 23,321 | $3.06 | $71.4K | 0 |
| Jun 2, 2025 | Joshi Mehul | Chief Financial Officer & PAO | Sell | 8,061 | $3.13 | $25.2K | 0 |
| Jun 2, 2025 | Lehman David Aaron | GENERAL COUNSEL | Sell | 10,457 | $3.13 | $32.7K | 0 |
| Jun 2, 2025 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,947 | $3.13 | $21.7K | 0 |
| Jun 2, 2025 | Williamson Steven S. | PRESIDENT AND CEO | Sell | 9,923 | $3.13 | $31.1K | 0 |
| Mar 20, 2025 | French Glendon E. III | Director | Sell | 20,000 | $7.85 | $157.0K | 0 |
| Mar 3, 2025 | Joshi Mehul | Chief Financial Officer & PAO | Sell | 14,384 | $7.12 | $102.4K | 0 |
| Mar 3, 2025 | Lehman David Aaron | GENERAL COUNSEL | Sell | 22,355 | $7.65 | $170.9K | 0 |
| Mar 3, 2025 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 5,779 | $7.13 | $41.2K | 0 |
| Mar 3, 2025 | Williamson Steven S. | PRESIDENT AND CEO | Sell | 27,689 | $7.14 | $197.7K | 0 |
| Feb 20, 2025 | French Glendon E. III | Director | Sell | 55,453 | $8.28 | $459.1K | 0 |
| Jan 21, 2025 | French Glendon E. III | Sell | 4,547 | $6.52 | $29.6K | 1,069,648 | |
| Dec 4, 2024 | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,497 | $6.19 | $34.0K | 202,938 |
| Dec 4, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,376 | $6.18 | $27.1K | 295,041 |
| Nov 26, 2024 | French Glendon E. III | Sell | 20,000 | $6.63 | $132.6K | 1,071,974 | |
| Oct 21, 2024 | French Glendon E. III | Sell | 20,000 | $6.52 | $130.4K | 1,091,974 | |
| Sep 18, 2024 | French Glendon E. III | Sell | 20,000 | $8.09 | $161.8K | 1,111,974 | |
| Sep 5, 2024 | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,765 | $6.69 | $38.6K | 208,684 |
| Sep 5, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,586 | $6.70 | $30.7K | 299,609 |
| Aug 22, 2024 | Williamson Steven S. | PRESIDENT AND CEO | Buy | 14,245 | $6.84 | $97.4K | 219,531 |
| Jun 26, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $6.16 | $7.3K | 300,019 |
| Jun 5, 2024 | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,475 | $6.97 | $38.2K | 214,179 |
| Jun 5, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,297 | $6.97 | $30.0K | 305,115 |
| May 23, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $8.71 | $10.3K | 305,500 |
| Apr 24, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $7.49 | $8.9K | 306,684 |
| Mar 26, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $9.36 | $11.1K | 307,868 |
| Mar 5, 2024 | French Glendon E. III | PRESIDENT AND CEO | Sell | 6,954 | $9.06 | $63.0K | 1,122,523 |
| Mar 5, 2024 | Lehman David Aaron | GENERAL COUNSEL | Sell | 4,351 | $9.06 | $39.4K | 149,380 |
| Mar 5, 2024 | McKune John | INTERIM CFO | Sell | 1,078 | $9.06 | $9.8K | 48,333 |
| Mar 5, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 3,097 | $9.06 | $28.1K | 242,621 |
| Feb 26, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $14.20 | $16.8K | 243,049 |
| Feb 16, 2024 | French Glendon E. III | PRESIDENT AND CEO | Sell | 20,000 | $14.60 | $292.0K | 1,121,344 |
| Jan 24, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $13.13 | $15.5K | 244,233 |
| Jan 22, 2024 | French Glendon E. III | PRESIDENT AND CEO | Sell | 10,000 | $12.77 | $127.7K | 1,141,344 |
| Dec 27, 2023 | Rose Geoffrey Beran | Chief Commercial Officer | Sell | 1,184 | $12.75 | $15.1K | 245,417 |
| Dec 22, 2023 | French Glendon E. III | President and CEO | Sell | 10,000 | $12.42 | $124.2K | 1,151,344 |
| Dec 5, 2023 | French Glendon E. III | President and CEO | Sell | 6,676 | $10.34 | $69.0K | 1,166,980 |
Showing 1–50 of 128
1 / 3
LUNG Insider Buying Activity
The following table shows recent insider purchases of Pulmonx Corporation (LUNG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | Florin Daniel P | Director | Buy | 23,321 | $3.06 | $71.4K | 0 |
| Aug 22, 2024 | Williamson Steven S. | PRESIDENT AND CEO | Buy | 14,245 | $6.84 | $97.4K | 219,531 |
LUNG Insider Selling Activity
The following table shows recent insider sales of Pulmonx Corporation (LUNG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Radhakrishnan Srikanth | officer: Chief Science & Techn. Officer | Sell | 14,245 | $2.26 | $32.2K | 328,596 |
| Sep 3, 2026 | Rose Geoffrey Beran | officer: Chief Commercial Officer | Sell | 7,879 | $2.26 | $17.8K | 455,498 |
| Sep 3, 2026 | French Glendon E. III | director, officer: President and CEO | Sell | 41,882 | $2.26 | $94.7K | 1,175,720 |
| Sep 3, 2026 | Lehman David Aaron | officer: General Counsel | Sell | 14,334 | $2.26 | $32.4K | 372,354 |
| Dec 8, 2025 | Florin Daniel P | Director | Sell | 23,321 | $1.99 | $46.4K | 0 |
| Dec 1, 2025 | French Glendon E. III | President and CEO | Sell | 8,805 | $1.57 | $13.8K | 0 |
| Dec 1, 2025 | Lehman David Aaron | GENERAL COUNSEL | Sell | 10,278 | $1.57 | $16.1K | 0 |
| Dec 1, 2025 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,322 | $1.57 | $9.9K | 0 |
| Sep 2, 2025 | Joshi Mehul | Chief Financial Officer & PAO | Sell | 7,936 | $1.60 | $12.7K | 0 |
| Sep 2, 2025 | Lehman David Aaron | GENERAL COUNSEL | Sell | 9,769 | $1.60 | $15.6K | 0 |
| Sep 2, 2025 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,543 | $1.60 | $10.5K | 0 |
| Sep 2, 2025 | Williamson Steven S. | PRESIDENT AND CEO | Sell | 9,648 | $1.60 | $15.4K | 0 |
| Jun 12, 2025 | Ferrari Richard | Director | Sell | 8,000 | $3.16 | $25.3K | 0 |
| Jun 2, 2025 | Joshi Mehul | Chief Financial Officer & PAO | Sell | 8,061 | $3.13 | $25.2K | 0 |
| Jun 2, 2025 | Lehman David Aaron | GENERAL COUNSEL | Sell | 10,457 | $3.13 | $32.7K | 0 |
| Jun 2, 2025 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,947 | $3.13 | $21.7K | 0 |
| Jun 2, 2025 | Williamson Steven S. | PRESIDENT AND CEO | Sell | 9,923 | $3.13 | $31.1K | 0 |
| Mar 20, 2025 | French Glendon E. III | Director | Sell | 20,000 | $7.85 | $157.0K | 0 |
| Mar 3, 2025 | Joshi Mehul | Chief Financial Officer & PAO | Sell | 14,384 | $7.12 | $102.4K | 0 |
| Mar 3, 2025 | Lehman David Aaron | GENERAL COUNSEL | Sell | 22,355 | $7.65 | $170.9K | 0 |
| Mar 3, 2025 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 5,779 | $7.13 | $41.2K | 0 |
| Mar 3, 2025 | Williamson Steven S. | PRESIDENT AND CEO | Sell | 27,689 | $7.14 | $197.7K | 0 |
| Feb 20, 2025 | French Glendon E. III | Director | Sell | 55,453 | $8.28 | $459.1K | 0 |
| Jan 21, 2025 | French Glendon E. III | Sell | 4,547 | $6.52 | $29.6K | 1,069,648 | |
| Dec 4, 2024 | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,497 | $6.19 | $34.0K | 202,938 |
| Dec 4, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,376 | $6.18 | $27.1K | 295,041 |
| Nov 26, 2024 | French Glendon E. III | Sell | 20,000 | $6.63 | $132.6K | 1,071,974 | |
| Oct 21, 2024 | French Glendon E. III | Sell | 20,000 | $6.52 | $130.4K | 1,091,974 | |
| Sep 18, 2024 | French Glendon E. III | Sell | 20,000 | $8.09 | $161.8K | 1,111,974 | |
| Sep 5, 2024 | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,765 | $6.69 | $38.6K | 208,684 |
| Sep 5, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,586 | $6.70 | $30.7K | 299,609 |
| Jun 26, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $6.16 | $7.3K | 300,019 |
| Jun 5, 2024 | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,475 | $6.97 | $38.2K | 214,179 |
| Jun 5, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,297 | $6.97 | $30.0K | 305,115 |
| May 23, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $8.71 | $10.3K | 305,500 |
| Apr 24, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $7.49 | $8.9K | 306,684 |
| Mar 26, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $9.36 | $11.1K | 307,868 |
| Mar 5, 2024 | French Glendon E. III | PRESIDENT AND CEO | Sell | 6,954 | $9.06 | $63.0K | 1,122,523 |
| Mar 5, 2024 | Lehman David Aaron | GENERAL COUNSEL | Sell | 4,351 | $9.06 | $39.4K | 149,380 |
| Mar 5, 2024 | McKune John | INTERIM CFO | Sell | 1,078 | $9.06 | $9.8K | 48,333 |
| Mar 5, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 3,097 | $9.06 | $28.1K | 242,621 |
| Feb 26, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $14.20 | $16.8K | 243,049 |
| Feb 16, 2024 | French Glendon E. III | PRESIDENT AND CEO | Sell | 20,000 | $14.60 | $292.0K | 1,121,344 |
| Jan 24, 2024 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $13.13 | $15.5K | 244,233 |
| Jan 22, 2024 | French Glendon E. III | PRESIDENT AND CEO | Sell | 10,000 | $12.77 | $127.7K | 1,141,344 |
| Dec 27, 2023 | Rose Geoffrey Beran | Chief Commercial Officer | Sell | 1,184 | $12.75 | $15.1K | 245,417 |
| Dec 22, 2023 | French Glendon E. III | President and CEO | Sell | 10,000 | $12.42 | $124.2K | 1,151,344 |
| Dec 5, 2023 | French Glendon E. III | President and CEO | Sell | 6,676 | $10.34 | $69.0K | 1,166,980 |
LUNG Insiders
Similar Stocks to LUNG
SYK
Stryker Corporation
$281.11-0.32%
$105.57B
BSX
Boston Scientific Corporation
$43.93-2.48%
$66.83B
EW
Edwards Lifesciences Corporation
$85.82+0.33%
$49.62B
DXCM
DexCom, Inc.
$86.69+2.37%
$31.33B
ZBH
Zimmer Biomet Holdings, Inc.
$99.10+2.61%
$18.09B
GMED
Globus Medical, Inc.
$74.78-1.29%
$10.01B
GKOS
Glaukos Corporation
$172.13+0.61%
$9.87B
PODD
Insulet Corp.
$139.63+1.32%
$9.14B